Goserelin EP Impurity E
Goserelin EP Impurity E is the impurity of Goserelin (HY-13673) [1].
Product Specifications
CAS Number
[147688-42-4]
UNSPSC
12352209
Hazard Statement
H302-H315-H319-H335
Target
Drug Derivative
Type
Peptides
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/goserelin-ep-impurity-e.html
Solubility
H2O
Smiles
O=C([C@H]1NC(CC1)=O)N[C@@H](CC2=CN=CN2)C(N[C@H](C(N[C@@H](CO)C(N[C@H](C(N[C@H](COC(C)(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N3[C@@H](CCC3)C(NN)=O)=O)=O)=O)=O)CC4=CC=C(C=C4)O)=O)=O)CC5=CNC6=CC=CC=C56)=O
Molecular Formula
C58H83N17O13
Molecular Weight
1226.39
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Kripa S. Srivastava, et al. Solid phase peptide synthesis process for the production of goserelin. Patent WO2010141276A1.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items